- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mi | Here is Why SLB (SLB) is One of the Best Performing S&P 500 Stocks | ||
| Mi | NVR, Inc. (NVR)'s First-quarter Profit Drops | ||
| Mi | Home Depot (HD) Solves a Critical Customer Pain Point to Win over Shoppers | ||
| Mi | Evercore ISI Maintains an "In Line" Rating on Lowe's Companies, Inc. (LOW) | ||
| Mi | Evercore ISI l Maintains an Underperform Rating on Lennar Corporation (LEN) | ||
| Mi | D.R. Horton (DHI) Beats Annual Revenue Forecast Estimates | ||
| Mi | BofA Retains a Neutral Rating on Builders FirstSource, Inc. (BLDR) | ||
| Mi | Evercore Maintains an "In Line" Rating on KB Home (KBH) | ||
| Mi | Toll Brothers (TOL) to Acquire Assets of Buffington Homes of Arkansas | ||
| Mi | Procter & Gamble (PG): The Best Consumer Staples Stock to Invest In | ||
| Mi | Stifel Maintains Buy Rating on Monster Beverage (MNST) | ||
| Mi | TD Cowen Maintains Buy Rating on e.l.f. Beauty (ELF) | ||
| Mi | Morgan Stanley Maintains Equal Weight Rating on J. M. Smucker (SJM) | ||
| Mi | BJ's Wholesale Club (BJ) Expands into Texas | ||
| Mi | JPMorgan Raises its Price Target on JBS N.V. (JBS) to $20.50 | ||
| Mi | JPMorgan Maintains Neutral Rating on Church & Dwight (CHD) | ||
| Mi | TD Cowen Maintains Hold Rating on Estée Lauder (EL) | ||
| Mi | BofA Maintains Buy Rating on Sysco (SYY) | ||
| Mi | KKR & Co. (KKR) Falls on Earnings Miss Despite Strong Fundraising Momentum and Long-Term Growth Plans | ||
| Mi | Corcept Therapeutics (CORT) Inspires Confidence with ROSELLA Phase 3 Survival Data | ||
| Mi | Beam Therapeutics (BEAM) Reveals Encouraging Results From Risto-Cel Phase 1/2 BEACON Study | ||
| Mi | Optimism Surrounds Praxis Precision Medicines (PRAX) Amid Potential FDA Approval for Ulixacaltamide | ||
| Mi | What Makes Denali Therapeutics (DNLI) One of the Best Biotech Stocks to Invest in | ||
| Mi | Ultragenyx Pharmaceutical (RARE) Garnering Bullish Sentiment With Forthcoming GTX-102 Phase 3 Angelman Trial | ||
| Mi | H.C. Wainwright Reaffirms Buy Rating for Legend Biotech (LEGN) |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.